Microangiography: An Alternative Tool for Assessing Severe Frostbite Injury.


Journal

Journal of burn care & research : official publication of the American Burn Association
ISSN: 1559-0488
Titre abrégé: J Burn Care Res
Pays: England
ID NLM: 101262774

Informations de publication

Date de publication:
14 08 2019
Historique:
pubmed: 13 7 2019
medline: 18 11 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

Assessment of frostbite injury typically relies on computed tomography, angiography, or nuclear medicine studies to detect perfusion deficits prior to thrombolytic therapy. The aim of this study was to evaluate the potential of a novel imaging method, microangiography, in the assessment of severe frostbite injury. Patients with severe frostbite were included if they received a post-thrombolytic Technetium 99 (Tc99) bone scan, a Tc99 bone scan without thrombolytic therapy, and/or post-thrombolytic microangiography (MA) study. We included all patients from the years 2006 to 2018 with severe frostbite injury who had received appropriate imaging for diagnosis: Tc99 scan alone (N = 82), microangiography alone (N = 22), and both Tc99 and microangiography (N = 26). The majority of patients received thrombolytic therapy (76.2%), and the average time to thrombolytics was 6.9 hours. Tc99 scans showed strong correlation with amputation level (r = .836, P < .001), and microangiography showed a slightly stronger positive correlation with amputation level (r = .870, P < .001). In the subset who received both Tc99 scan and microangiography (N = 26), we observed significant differences in the mean scores of perfusion deficit (z = 3.20, P < .001). In this subset, a moderate correlation was found between level of perfusion deficit on Tc99 bone scan and amputation level (r = .525, P = .006). A very strong positive correlation was found between the microangiography studies and the amputation level (r = .890, P < .001). These results demonstrate that microangiography is a reliable alternative method of assessing severe frostbite injury and predicting amputation level.

Identifiants

pubmed: 31298700
pii: 5531684
doi: 10.1093/jbcr/irz112
doi:

Substances chimiques

Technetium-99 0
Technetium 7440-26-8

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

566-569

Informations de copyright

© American Burn Association 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Alexandra M Lacey (AM)

Hennepin Healthcare, Minneapolis, MN.

Ryan M Fey (RM)

Hennepin Healthcare, Minneapolis, MN.

Jon R Gayken (JR)

Hennepin Healthcare, Minneapolis, MN.

Frederick W Endorf (FW)

Hennepin Healthcare, Minneapolis, MN.

Kyle R Schmitz (KR)

Hennepin Healthcare, Minneapolis, MN.

Gopal V Punjabi (GV)

Hennepin Healthcare, Minneapolis, MN.

Thomas C Masters (TC)

Hennepin Healthcare, Minneapolis, MN.

Rachel M Nygaard (RM)

Hennepin Healthcare, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH